Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Sham-controlled, Comparative Study of SI-6603 in Subjects With Lumbar Disc Herniation (Phase 3)
Conditions
Interventions
SI-6603
Sham injection
Locations
67
United States
Delta Clinical Research
Mobile, Alabama, United States
Pain Medicine Associates, Inc.
Fountain Valley, California, United States
University of California San Diego - Center for Pain Medicine
La Jolla, California, United States
The Helm Center for Pain Management
Laguna Woods, California, United States
The Anand Spine Group
Los Angeles, California, United States
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States
Start Date
November 7, 2018
Primary Completion Date
August 3, 2022
Completion Date
March 21, 2023
Last Updated
July 24, 2025
NCT05029726
NCT07413302
NCT07349719
NCT06853132
NCT07161232
NCT04540068
Lead Sponsor
Seikagaku Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions